1. [SCIE] Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes [FRONTIERS IN PHARMACOLOGY] - 2025-12-01 2. [SCIE] Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of rhIL-7-hyFc, a Hybrid Fc-Fused Long-Acting Interleukin-7, to Support Optimal Dosing Regimens in Patients with Solid Cancer [DRUG DESIGN DEVELOPMENT AND THERAPY] - 2025-10-17 3. [SCIE] Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab [Frontiers in Pharmacology] - 2025-08-19 4. [SCIE] Pharmacokinetic and Pharmacodynamic Modeling Analysis of Delpazolid (LCB01-0371) in Adult Patients with Pulmonary Tuberculosis [JOURNAL OF CLINICAL PHARMACOLOGY] - 2024-07-01 5. [SCIE] PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy [PHARMACEUTICALS] - 2024-02-26